Journal Article

Effects of five types of selenium supplementation for treatment of Kashin-Beck disease in children: a systematic review and network meta-analysis

Deng, Chuanyao, Yue, Jirong, Wang, Yanyan, Xie, Dongmei, Zhang, Chao, Liao, Yulin, Chen, Ling

2018

Overview

ObjectiveTo compare the effectiveness of five kinds of selenium supplementation for the treatment of patients with Kashin-Beck disease, and rank these selenium supplementations based on their performance.DesignWe searched for all publications between 1 January 1966 and 31 March 2017 using seven electronic databases. GRADE system to network meta-analyses (NMAs) was applied to rate the quality of the evidence. We conducted a random effects model NMA in STATA 12.1 to determine comparative effectiveness of each intervention. Rankings were obtained by using the surface under the cumulative ranking curve (SUCRA) values and mean ranks.ResultsA total of 15 randomised controlled trials involving 2931 patients were included. After assessment of the overall quality of the evidence, we downgraded our primary outcomes from high to low or very low quality. NMAs showed that all five kinds of selenium supplementation had higher metaphysis X-ray improvement which were superior to placebo. Ranking on efficacy indicated that selenium salt was ranked the highest, followed by sodium selenite + vitamin E, selenium enriched yeast, sodium selenite and then sodium selenite + vitamin C.ConclusionsBased on the results of NMA, all five types of selenium supplements are more effective than placebo and so that selenium supplementation is of help in repairing metaphyseal lesions. Since the overall quality of the evidence was low or very low, the SUCRA values may be misleading and should be considered jointly with the The Grading of Recommendations Assessment, Development and Evaluation (GRADE) confidence in the estimates for each comparison. The quality of the evidence is insufficient to draw a conclusion about what method of selenium supplementation is most effective.PROSPERO registration number CRD42016051874.

• Publisher: BMJ Publishing Group LTD,BMJ Publishing Group
• Subject: Adolescent / Bone and Bones - drug effects / Bone and Bones - pathology / Bone diseases / Child / Child, Preschool / Childrens health / Dietary Supplements / Estimates / Evidence Based Practice / Evidence-based medicine / Female / Growth disorders / Humans / Iodine / Kashin-Beck Disease - drug therapy / Kashin-Beck Disease - pathology / Male / Meta-analysis / Metabolism / Quality / Radiography / Selenium / Selenium - pharmacology / Selenium - therapeutic use / Selenium Compounds - pharmacology / Selenium Compounds - therapeutic use / Sodium / Systematic review / Working groups / Yeast